Rivaroxaban Reduces First and Total Ischemic Events in Patients with Peripheral Artery Disease
Rivaroxaban, in addition to low-dose aspirin, significantly reduced the occurrence of total severe events of the heart, limb or brain and issues related to other vascular complications in…
Heart-Protecting Drugs Likely Unnecessary for Many Breast Cancer Patients
Taking medications to protect the heart from damage associated with adjuvant breast cancer therapy—medications that are administered in addition to surgery to remove a tumor—did not significantly improve…
Higher Blood Levels of Omega-3 Fatty Acids from Prescription Fish Oil Showed No Effect on Cardiovascular Events
Patients at high risk for cardiovascular events who had the highest levels of eicosapentaenoic acid (EPA) in their blood one year after taking daily omega-3 carboxylic acid, a…
Sacubitril/Valsartan Not Superior to Valsartan for Advanced Heart Failure
Trial finds no benefit from combination therapy for heart failure with reduced ejection fraction
Sotagliflozin Shows Benefit for Difficult-to-Treat Form of Heart Failure
Drug reduced cardiovascular adverse events in patients with diabetes and heart failure